UK Chemiluminescence Immunoassay Market Size & Outlook
UK chemiluminescence immunoassay market, 2016-2028 (US$M)
Related Markets
UK chemiluminescence immunoassay market highlights
- The UK chemiluminescence immunoassay market generated a revenue of USD 277.3 million in 2020 and is expected to reach USD 573.3 million by 2028.
- The UK market is expected to grow at a CAGR of 9.5% from 2021 to 2028.
- In terms of segment, consumables was the largest revenue generating product & services in 2020.
- Consumables is the most lucrative product & services segment registering the fastest growth during the forecast period.
Chemiluminescence immunoassay market data book summary
| Market revenue in 2020 | USD 277.3 million |
| Market revenue in 2028 | USD 573.3 million |
| Growth rate | 9.5% (CAGR from 2020 to 2028) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Software & Services |
| Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
Other key industry trends
- In terms of revenue, UK accounted for 3.8% of the global chemiluminescence immunoassay market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany chemiluminescence immunoassay market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 573.3 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chemiluminescence Immunoassay Market Scope
Chemiluminescence Immunoassay Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK chemiluminescence immunoassay market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.03% in 2020. Horizon Databook has segmented the UK chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
The UK chemiluminescence immunoassay market is growing primarily due to high demand for diagnostics, which can be attributed to increase in the prevalence of chronic diseases. In addition, presence of sophisticated healthcare infrastructure, high disposable income, and growing awareness about early diagnosis of diseases are among key factors driving the market growth in this country.
Furthermore, high adoption of technologically advanced products, such as automated instruments, and continuous government initiatives to fulfill growing healthcare needs are anticipated to be major factors contributing to the market growth. In May 2020, Abbott received a contract from NHS UK to supply millions of laboratory-based IgG antibody tests for conducting mass COVID-19 testing in the country.
Reasons to subscribe to UK chemiluminescence immunoassay market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK chemiluminescence immunoassay market databook
-
Our clientele includes a mix of chemiluminescence immunoassay market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into UK chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
UK chemiluminescence immunoassay market size, by product & services, 2016-2028 (US$M)
UK Chemiluminescence Immunoassay Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
